Assessment of bidirectional impact of stigmatization induced self-medication on COVID-19 and malaria transmissions using mathematical modeling: Nigeria as a case study
Mathematical Biosciences · 2024
DOI: 10.1016/j.mbs.2024.109249 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mathematical Biosciences, 2024. Verfasst von Wisdom S Avusuglo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Africa-Canada Artificial Intelligence and Data Innovation Consortium (ACADIC), York University, Canada; Laboratory for Industrial and Applied Mathema…. Hauptthemen laut MEDLINE: COVID-19, Self Medication, Malaria, Models, Theoretical. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The continual social and economic impact of infectious diseases on nations has maintained sustained attention on their control and treatment, of which self-medication has been one of the means employed by some individuals. Self-medication complicates the attempt of their control and treatment as it conflicts with some of the measures implemented by health authorities. Added to these complications is the stigmatization of individuals with some diseases in some jurisdictions. This study investigates the co-infection of COVID-19 and malaria and its related deaths and further highlights how self-medication and stigmatization add to the complexities of the fight against these two diseases using Nigeria as a study case. Using a mathematical model on COVID-19 and malaria co-infection, we address the question: to what degree does the impact of the interaction between COVID-19 and malaria amplify infections and deaths induced by both diseases via self-medication and stigmatization? We demonstrate that COVID-19 related self-medication due to misdiagnoses contributes substantially to the prevalence of disease. The control reproduction numbers for these diseases and quantification of model parameters uncertainties and sensitivities are presented.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Africa-Canada Artificial Intelligence and Data Innovation Consortium (ACADIC), York University, Canada; Laboratory for Industrial and Applied Mathematics (LIAM), Department of Mathematics and Statistics, York University…
- Africa-Canada Artificial Intelligence and Data Innovation Consortium (ACADIC), York University, Canada; The Dahdaleh Institute for Global Health Research, York University, Canada.
- Africa-Canada Artificial Intelligence and Data Innovation Consortium (ACADIC), York University, Canada; K. N. Toosi University of Technology, Faculty of Computer Engineering, Iran.
- Africa-Canada Artificial Intelligence and Data Innovation Consortium (ACADIC), York University, Canada; Artificial Intelligence & Mathematical Modeling Lab (AIMM Lab), Dalla Lana School of Public Health, University of T…
Zitieren
APA
Avusuglo, W. S., Han, Q., Woldegerima, W. A., Asgary, A., Wu, J., Orbinski, J., Bragazzi, N., Ahmadi, A., & Kong, J. D. (2024). Assessment of bidirectional impact of stigmatization induced self-medication on COVID-19 and malaria transmissions using mathematical modeling: Nigeria as a case study. Mathematical Biosciences. https://doi.org/10.1016/j.mbs.2024.109249
Vancouver
Avusuglo WS, Han Q, Woldegerima WA, Asgary A, Wu J, Orbinski J, et al. Assessment of bidirectional impact of stigmatization induced self-medication on COVID-19 and malaria transmissions using mathematical modeling: Nigeria as a case study. Mathematical Biosciences. 2024. doi:10.1016/j.mbs.2024.109249
BibTeX
@article{Avusuglo2024,
author = {Avusuglo, Wisdom S and Han, Qing and Woldegerima, Woldegebriel Assefa and Asgary, Ali and Wu, Jianhong and Orbinski, James and Bragazzi, Nicola and Ahmadi, Ali and Kong, Jude Dzevela},
title = {Assessment of bidirectional impact of stigmatization induced self-medication on COVID-19 and malaria transmissions using mathematical modeling: Nigeria as a case study},
journal = {Mathematical Biosciences},
year = {2024},
doi = {10.1016/j.mbs.2024.109249}
}
EUVIMED